Trial intelligence / Profile preview

Ovulation Inhibition with Gestodene/EE Patches

NCT01204190Phase 2Completed

Sponsor
Bayer
Start
Sep 2010
Primary completion
Jul 2011
Modality
Small Molecules
Countries
2
01

Overview

A Phase 2 trial of ethinyl estradiol, gestodene in contraception, sponsored by Bayer. Started Sep 2010; status: completed.

02

Drugs

ethinyl estradiolgestodene
03

Conditions

contraception

Beyond the preview

Go deeper on NCT01204190.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01204190.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call